Congenital cytomegalovirus infection in pregnancy and the neonate: consensus recommendations for prevention, diagnosis, and therapy (Q28950688)

21 June 2017

Congenital cytomegalovirus infection in pregnancy and the neonate: consensus recommendations for prevention, diagnosis, and therapy (English)

1 reference

congenital cytomegalovirus infection

21 June 2017

0 references

0 references

0 references

1 reference

Lisa Hui

14

0 references

David W Kimberlin

4

object named as

David W Kimberlin

1 reference

21 June 2017

Pamela Palasanthiran

16

1 reference

ORCID Public Data File 2021

Michelle L. Giles

1 reference

ORCID Public Data File 2021

Mark R Schleiss

17

object named as

Mark R Schleiss

1 reference

21 June 2017

William D Rawlinson

1

1 reference

21 June 2017

Suresh B Boppana

2

1 reference

21 June 2017

Karen B Fowler

3

1 reference

21 June 2017

Tiziana Lazzarotto

5

1 reference

21 June 2017

Sophie Alain

6

1 reference

21 June 2017

Kate Daly

7

1 reference

21 June 2017

Sara Doutré

8

1 reference

21 June 2017

Laura Gibson

9

1 reference

21 June 2017

Michelle L Giles

10

1 reference

21 June 2017

Janelle Greenlee

11

1 reference

21 June 2017

Stuart T Hamilton

12

1 reference

21 June 2017

Gail J Harrison

13

1 reference

21 June 2017

Cheryl A Jones

15

1 reference

21 June 2017

Antonia W Shand

18

1 reference

21 June 2017

Wendy J van Zuylen

19

1 reference

21 June 2017

March 2017

0 references

10 March 2017

1 reference

Lancet Infectious Diseases

21 June 2017

2 references

21 June 2017

17

1 reference

21 June 2017

6

1 reference

21 June 2017

e177-e188

1 reference

Birth prevalence and natural history of congenital cytomegalovirus infection in a highly seroimmune population

21 June 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2817%2930143-3

7 January 2021

Review and meta-analysis of the epidemiology of congenital cytomegalovirus (CMV) infection

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2817%2930143-3

7 January 2021

The "silent" global burden of congenital cytomegalovirus

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2817%2930143-3

7 January 2021

Prevention of congenital cytomegalovirus complications by maternal and neonatal treatments: a systematic review.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2817%2930143-3

7 January 2021

Newborn hearing screening vs later hearing screening and developmental outcomes in children with permanent childhood hearing impairment.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2817%2930143-3

7 January 2021

Valganciclovir for symptomatic congenital cytomegalovirus disease

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2817%2930143-3

7 January 2021

Congenital cytomegalovirus: Public health action towards awareness, prevention, and treatment.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2817%2930143-3

7 January 2021

International consensus guidelines on the management of cytomegalovirus in solid organ transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2817%2930143-3

7 January 2021

Towards early inclusion of children in tuberculosis drugs trials: a consensus statement

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2817%2930143-3

7 January 2021

Management of viral hepatitis in patients with haematological malignancy and in patients undergoing haemopoietic stem cell transplantation: recommendations of the 5th European Conference on Infections in Leukaemia (ECIL-5).

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2817%2930143-3

7 January 2021

Cytomegalovirus in pregnancy: to screen or not to screen

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2817%2930143-3

7 January 2021

Congenital cytomegalovirus infection following first trimester maternal infection: symptoms at birth and outcome.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2817%2930143-3

7 January 2021

Prevention of child-to-mother transmission of cytomegalovirus by changing behaviors: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2817%2930143-3

7 January 2021

Prevention of Primary Cytomegalovirus Infection in Pregnancy.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2817%2930143-3

7 January 2021

Does hygiene counseling have an impact on the rate of CMV primary infection during pregnancy? Results of a 3-year prospective study in a French hospital

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2817%2930143-3

7 January 2021

Prevention of child-to-mother transmission of cytomegalovirus among pregnant women

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2817%2930143-3

7 January 2021

Cytomegalovirus and child day care: risk factors for maternal infection

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2817%2930143-3

7 January 2021

Factors predictive of cytomegalovirus immune status in pregnant women

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2817%2930143-3

7 January 2021

Acquisition of cytomegaloviral infections in families with young children: a serological study.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2817%2930143-3

7 January 2021

Factors associated with primary cytomegalovirus infection during pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2817%2930143-3

7 January 2021

Congenital cytomegalovirus infection: The relative importance of primary and recurrent maternal infection

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2817%2930143-3

7 January 2021

Attribution of congenital cytomegalovirus infection to primary versus non-primary maternal infection.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2817%2930143-3

7 January 2021

Long-term outcomes of congenital cytomegalovirus infection in Sweden and the United Kingdom

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2817%2930143-3

7 January 2021

Intrauterine transmission of cytomegalovirus to infants of women with preconceptional immunity

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2817%2930143-3

7 January 2021

Cytomegalovirus reinfections in healthy seroimmune women

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2817%2930143-3

7 January 2021

Human cytomegalovirus reinfection is associated with intrauterine transmission in a highly cytomegalovirus-immune maternal population

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2817%2930143-3

7 January 2021

Fetal effects of primary and secondary cytomegalovirus infection in pregnancy.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2817%2930143-3

7 January 2021

Congenital cytomegalovirus infection as a cause of sensorineural hearing loss in a highly immune population

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2817%2930143-3

7 January 2021

Report on a long-term study of maternal and congenital cytomegalovirus infection in Sweden. Review of prospective studies available in the literature

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2817%2930143-3

7 January 2021

Congenital cytomegalovirus infection after recurrent infection: case reports and review of the literature

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2817%2930143-3

7 January 2021

Secondary cytomegalovirus infection can cause severe fetal sequelae despite maternal preconceptional immunity

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2817%2930143-3

7 January 2021

Symptomatic congenital cytomegalovirus infection in infants born to mothers with preexisting immunity to cytomegalovirus

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2817%2930143-3

7 January 2021

Hearing loss in children with congenital cytomegalovirus infection born to mothers with preexisting immunity.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2817%2930143-3

7 January 2021

Clinical manifestations and abnormal laboratory findings in pregnant women with primary cytomegalovirus infection

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2817%2930143-3

7 January 2021

Diagnosis and management of human cytomegalovirus infection in the mother, fetus, and newborn infant

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2817%2930143-3

7 January 2021

Diagnosis of and screening for cytomegalovirus infection in pregnant women.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2817%2930143-3

7 January 2021

Maternal IgG avidity and IgM detected by blot as diagnostic tools to identify pregnant women at risk of transmitting cytomegalovirus

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2817%2930143-3

7 January 2021

A serological testing algorithm for the diagnosis of primary CMV infection in pregnant women.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2817%2930143-3

7 January 2021

Update on the prevention, diagnosis and management of cytomegalovirus infection during pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2817%2930143-3

7 January 2021

Role of cytomegalovirus (CMV) IgG avidity testing in diagnosing primary CMV infection during pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2817%2930143-3

7 January 2021

Improving diagnosis of primary cytomegalovirus infection in pregnant women using immunoblots

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2817%2930143-3

7 January 2021

The value of CMV IgG avidity and immunoblot for timing the onset of primary CMV infection in pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2817%2930143-3

7 January 2021

MRI and ultrasound fusion imaging for prenatal diagnosis.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2817%2930143-3

7 January 2021

Risk of fetal loss associated with invasive testing following combined first-trimester screening for Down syndrome: a national cohort of 147,987 singleton pregnancies.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2817%2930143-3

7 January 2021

Accuracy of amniotic fluid testing before 21 weeks' gestation in prenatal diagnosis of congenital cytomegalovirus infection

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2817%2930143-3

7 January 2021

Pathogenesis and prenatal diagnosis of human cytomegalovirus infection

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2817%2930143-3

7 January 2021

Prenatal indicators of congenital cytomegalovirus infection

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2817%2930143-3

7 January 2021

Prenatal diagnosis of symptomatic congenital cytomegalovirus infection

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2817%2930143-3

7 January 2021

Feasibility of predicting the outcome of fetal infection with cytomegalovirus at the time of prenatal diagnosis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2817%2930143-3

7 January 2021

Does normal fetal brain ultrasound predict normal neurodevelopmental outcome in congenital cytomegalovirus infection?

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2817%2930143-3

7 January 2021

Ultrasound prediction of symptomatic congenital cytomegalovirus infection

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2817%2930143-3

7 January 2021

The prognostic value of ultrasound abnormalities and biological parameters in blood of fetuses infected with cytomegalovirus

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2817%2930143-3

7 January 2021

A Prognostic Neonatal Neuroimaging Scale for Symptomatic Congenital Cytomegalovirus Infection.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2817%2930143-3

7 January 2021

Comparison between ultrasound and magnetic resonance imaging in assessment of fetal cytomegalovirus infection

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2817%2930143-3

7 January 2021

Value of prenatal ultrasound and magnetic resonance imaging in assessment of congenital primary cytomegalovirus infection

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2817%2930143-3

7 January 2021

Clinical predictive value of real-time PCR quantification of human cytomegalovirus DNA in amniotic fluid samples

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2817%2930143-3

7 January 2021

Prenatal Diagnostic and Prognostic Value of Human Cytomegalovirus Load and IgM Antibody Response in Blood of Congenitally Infected Fetuses

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2817%2930143-3

7 January 2021

Prognostic markers of symptomatic congenital cytomegalovirus infection

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2817%2930143-3

7 January 2021

Identification of Symptomatic Fetuses Infected with Cytomegalovirus Using Amniotic Fluid Peptide Biomarkers

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2817%2930143-3

7 January 2021

Prognostic markers of symptomatic congenital human cytomegalovirus infection in fetal blood

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2817%2930143-3

7 January 2021

Prenatal diagnosis of congenital cytomegalovirus infection by detection of immunoglobulin M antibodies to the 70-kd heat shock protein in fetal serum

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2817%2930143-3

7 January 2021

Prenatal diagnosis of congenital cytomegalovirus infection in 189 pregnancies with known outcome.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2817%2930143-3

7 January 2021

Vaccine prevention of maternal cytomegalovirus infection

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2817%2930143-3

7 January 2021

Safety and efficacy of a cytomegalovirus glycoprotein B (gB) vaccine in adolescent girls: A randomized clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2817%2930143-3

7 January 2021

Human cytomegalovirus quantification in toddlers saliva from day care centers and emergency unit: a feasibility study.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2817%2930143-3

7 January 2021

Cytomegalovirus survival on common environmental surfaces: opportunities for viral transmission.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2817%2930143-3

7 January 2021

Cytomegalovirus survival and transferability and the effectiveness of common hand-washing agents against cytomegalovirus on live human hands

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2817%2930143-3

7 January 2021

Repeated measures study of weekly and daily cytomegalovirus shedding patterns in saliva and urine of healthy cytomegalovirus-seropositive children

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2817%2930143-3

7 January 2021

Hygiene interventions for prevention of cytomegalovirus infection among childbearing women: systematic review

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2817%2930143-3

7 January 2021

Awareness of and attitudes toward congenital cytomegalovirus infection among pregnant women in Singapore

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2817%2930143-3

7 January 2021

Knowledge and awareness of congenital cytomegalovirus among women

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2817%2930143-3

7 January 2021

Observational study to assess pregnant women's knowledge and behaviour to prevent toxoplasmosis, listeriosis and cytomegalovirus

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2817%2930143-3

7 January 2021

Awareness of and behaviors related to child-to-mother transmission of cytomegalovirus

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2817%2930143-3

7 January 2021

Awareness of and knowledge about mother-to-child infections in Japanese pregnant women

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2817%2930143-3

7 January 2021

Awareness of Cytomegalovirus Infection among Pregnant Women in Geneva, Switzerland: A Cross-sectional Study

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2817%2930143-3

7 January 2021

Awareness of cytomegalovirus and risk factors for susceptibility among pregnant women, in Montreal, Canada

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2817%2930143-3

7 January 2021

Survey of congenital cytomegalovirus (cCMV) knowledge among medical students

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2817%2930143-3

7 January 2021

Awareness of congenital cytomegalovirus among doctors in the Netherlands

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2817%2930143-3

7 January 2021

Awareness and knowledge of congenital cytomegalovirus infection among health care providers in France

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2817%2930143-3

7 January 2021

An email survey of midwives knowledge about CytoMegaloVirus (CMV) in Hannover and a skeletal framework for a proposed teaching program.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2817%2930143-3

7 January 2021

The apparent paradox of maternal seropositivity as a risk factor for congenital cytomegalovirus infection: a population-based prediction model.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2817%2930143-3

7 January 2021

Passive Immunization during Pregnancy for Congenital Cytomegalovirus Infection

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2817%2930143-3

7 January 2021

A randomized trial of hyperimmune globulin to prevent congenital cytomegalovirus.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2817%2930143-3

7 January 2021

Use of cytomegalovirus hyperimmunoglobulin for prevention of congenital cytomegalovirus disease: a retrospective analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2817%2930143-3

7 January 2021

Primary maternal cytomegalovirus infections during pregnancy: association of CMV hyperimmune globulin with gestational age at birth and birth weight

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2817%2930143-3

7 January 2021

Hyperimmune globulin to prevent congenital CMV infection

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2817%2930143-3

7 January 2021

Maternal administration of valaciclovir in symptomatic intrauterine cytomegalovirus infection

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2817%2930143-3

7 January 2021

Immunoglobulin therapy of fetal cytomegalovirus infection occurring in the first half of pregnancy--a case-control study of the outcome in children.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2817%2930143-3

7 January 2021

Early primary cytomegalovirus infection in pregnancy: maternal hyperimmunoglobulin therapy improves outcomes among infants at 1 year of age.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2817%2930143-3

7 January 2021

Fetal hyperechogenic bowel may indicate congenital cytomegalovirus disease responsive to immunoglobulin therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2817%2930143-3

7 January 2021

Foscarnet treatment of genital infection due to acyclovir-resistant herpes simplex virus type 2 in a pregnant patient with AIDS: case report

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2817%2930143-3

7 January 2021

Successful use of oral ganciclovir for the treatment of intrauterine cytomegalovirus infection in a renal allograft recipient

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2817%2930143-3

7 January 2021

Placental transfer of ganciclovir in a woman with acquired immunodeficiency syndrome and cytomegalovirus disease

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2817%2930143-3

7 January 2021

Absence of teratogenicity of oral ganciclovir used during early pregnancy in a liver transplant recipient

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2817%2930143-3

7 January 2021

Valacyclovir for the prevention of cytomegalovirus disease after renal transplantation. International Valacyclovir Cytomegalovirus Prophylaxis Transplantation Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2817%2930143-3

7 January 2021

Adverse pregnancy outcome in women exposed to acyclovir during pregnancy: a population-based observational study

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2817%2930143-3

7 January 2021

The outcomes of pregnancy in women exposed to newly marketed drugs in general practice in England

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2817%2930143-3

7 January 2021

Pregnancy outcomes following systemic prenatal acyclovir exposure: Conclusions from the international acyclovir pregnancy registry, 1984-1999.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2817%2930143-3

7 January 2021

Use of acyclovir, valacyclovir, and famciclovir in the first trimester of pregnancy and the risk of birth defects

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2817%2930143-3

7 January 2021

In utero treatment of congenital cytomegalovirus infection with valacyclovir in a multicenter, open-label, phase II study

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2817%2930143-3

7 January 2021

Hearing loss and congenital CMV infection: a systematic review.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2817%2930143-3

7 January 2021

Universal newborn screening for congenital CMV infection: what is the evidence of potential benefit?

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2817%2930143-3

7 January 2021

Language ability after early detection of permanent childhood hearing impairment.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2817%2930143-3

7 January 2021

First estimates of the potential cost and cost saving of protecting childhood hearing from damage caused by congenital CMV infection

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2817%2930143-3

7 January 2021

Neurological outcomes in symptomatic congenital cytomegalovirus-infected infants after introduction of newborn urine screening and antiviral treatment

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2817%2930143-3

7 January 2021

Cost-benefit analysis of targeted hearing directed early testing for congenital cytomegalovirus infection.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2817%2930143-3

7 January 2021

Cost-effectiveness of Universal and Targeted Newborn Screening for Congenital Cytomegalovirus Infection

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2817%2930143-3

7 January 2021

Universal neonatal cytomegalovirus screening using saliva - report of clinical experience

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2817%2930143-3

7 January 2021

Evaluating the feasibility of integrating salivary testing for congenital CMV into the Newborn Hearing Screening Programme in the UK.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2817%2930143-3

7 January 2021

Screening for congenital cytomegalovirus infection using newborn urine samples collected on filter paper: feasibility and outcomes from a multicentre study

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2817%2930143-3

7 January 2021

Dried blood spot real-time polymerase chain reaction assays to screen newborns for congenital cytomegalovirus infection

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2817%2930143-3

7 January 2021

Evaluation of DNA extraction methods for the detection of Cytomegalovirus in dried blood spots

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2817%2930143-3

7 January 2021

Is saliva as reliable as urine for detection of cytomegalovirus DNA for neonatal screening of congenital CMV infection?

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2817%2930143-3

7 January 2021

Saliva polymerase-chain-reaction assay for cytomegalovirus screening in newborns

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2817%2930143-3

7 January 2021

Epidemiology of transmission of cytomegalovirus from mother to preterm infant by breastfeeding

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2817%2930143-3

7 January 2021

Newborn screening of congenital cytomegalovirus infection using saliva can be influenced by breast feeding.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2817%2930143-3

7 January 2021

Ganciclovir treatment of symptomatic congenital cytomegalovirus infection: results of a phase II study. National Institute of Allergy and Infectious Diseases Collaborative Antiviral Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2817%2930143-3

7 January 2021

Effect of ganciclovir therapy on hearing in symptomatic congenital cytomegalovirus disease involving the central nervous system: a randomized, controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2817%2930143-3

7 January 2021

Neurodevelopmental outcomes following ganciclovir therapy in symptomatic congenital cytomegalovirus infections involving the central nervous system

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2817%2930143-3

7 January 2021

Ganciclovir therapy for congenital cytomegalovirus infection in six infants

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2817%2930143-3

7 January 2021

Ganciclovir therapy for symptomatic congenital cytomegalovirus infection in infants: a two-regimen experience.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2817%2930143-3

7 January 2021

Effect on hearing of ganciclovir therapy for asymptomatic congenital cytomegalovirus infection: four to 10 year follow up.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2817%2930143-3

7 January 2021

Oral valganciclovir treatment in newborns with symptomatic congenital cytomegalovirus infection.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2817%2930143-3

7 January 2021

Treatment of symptomatic congenital cytomegalovirus infection beyond the neonatal period

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2817%2930143-3

7 January 2021

Pharmacokinetic and pharmacodynamic assessment of oral valganciclovir in the treatment of symptomatic congenital cytomegalovirus disease

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2817%2930143-3

7 January 2021

10.1016/S1473-3099(17)30143-3

Identifiers

DOI

1 reference

21 June 2017

1 reference